Diabetes 50:113-122, 2001
© 2001 by the American Diabetes Association, Inc.
Mechanism of Amelioration of Insulin Resistance by ß3-Adrenoceptor Agonist AJ-9677 in the KK-Ay/Ta Diabetic Obese Mouse Model
Hiroshi Kato,
Mayumi Ohue,
Kaori Kato,
Akinori Nomura,
Kaoru Toyosawa,
Yasuji Furutani,
Satoshi Kimura, and
Takashi Kadowaki
From the Department of Pharmacology III (H.K., M.O., K.K., Y.F.),
Discovery Research Laboratories; the Research and Development Coordination
(A.N.) and the Department of Toxicology (K.T.), Developmental Research
Laboratories, Dainippon Pharmaceutical Co., Osaka; and the Department of
Metabolic Diseases (H.K., S.K., T.K.), Graduate School of Medicine, University
of Tokyo, Tokyo, Japan.
Address correspondence and reprint requests to Hiroshi Kato, Department of
Pharmacology III, Discovery Research Laboratories, Dainippon Pharmaceutical
Co., Ltd., Osaka 564-0053, Japan. E-mail:
hiroshi-kato{at}dainippon-pharm.co.jp
.
The mechanism by which the specific ß3-adrenoceptor agonist
AJ-9677 relieves insulin resistance in vivo was investigated by studying its
effects in the white and brown adipose tissues of the
KK-Ay/Ta diabetic obese mouse model. AJ-9677 reduced the
total weight of white adipose tissues by reducing the size of the adipocytes,
an effect associated with the normalization of tumor necrosis factor-
(TNF- ) and leptin expression levels. The levels of uncoupling protein
(UCP)-1 mRNA in brown adipose tissue were increased threefold. AJ-9677 caused
a marked increase (20- to 80-fold) in the expression of UCP-1 in white adipose
tissues. The levels of UCP-2 mRNA were increased in both the white and brown
adipose tissues of diabetic obese mice, and AJ-9677 further upregulated UCP-2
mRNA levels in brown adipose tissue, but reduced its levels in white adipose
tissue. UCP-3 mRNA levels were not essentially changed by AJ-9677. However,
AJ-9677 significantly (two- to four-fold) upregulated the GLUT4 mRNA and
protein levels in white and brown adipose tissues and the gastrocnemius. The
generation of small adipocytes, presumably mediated by increased expression of
UCP-1 in addition to increased lipolysis in response to AJ-9677, was
associated with decreased TNF- and free fatty acid production and may
be the mechanism of amelioration of insulin resistance in
KK-Ay/Ta diabetic obese mice.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Serino, R. Menghini, L. Fiorentino, R. Amoruso, A. Mauriello, D. Lauro, P. Sbraccia, M. L. Hribal, R. Lauro, and M. Federici
Mice Heterozygous for Tumor Necrosis Factor-{alpha} Converting Enzyme Are Protected From Obesity-Induced Insulin Resistance and Diabetes
Diabetes,
October 1, 2007;
56(10):
2541 - 2546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Hampton, M. W. Knuth, J. Li, J. L. Harris, S. A. Lesley, and G. Spraggon
The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain
PNAS,
September 11, 2007;
104(37):
14604 - 14609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Redman, L. de Jonge, X. Fang, B. Gamlin, D. Recker, F. L. Greenway, S. R. Smith, and E. Ravussin
Lack of an Effect of a Novel {beta}3-Adrenoceptor Agonist, TAK-677, on Energy Metabolism in Obese Individuals: A Double-Blind, Placebo-Controlled Randomized Study
J. Clin. Endocrinol. Metab.,
February 1, 2007;
92(2):
527 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kim, P. A. Pennisi, O. Gavrilova, S. Pack, W. Jou, J. Setser-Portas, J. East-Palmer, Y. Tang, V. C. Manganiello, and D. LeRoith
Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice
Am J Physiol Endocrinol Metab,
June 1, 2006;
290(6):
E1227 - E1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Granneman, P. Li, Z. Zhu, and Y. Lu
Metabolic and cellular plasticity in white adipose tissue I: effects of {beta}3-adrenergic receptor activation
Am J Physiol Endocrinol Metab,
October 1, 2005;
289(4):
E608 - E616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Li, Z. Zhu, Y. Lu, and J. G. Granneman
Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-{alpha}
Am J Physiol Endocrinol Metab,
October 1, 2005;
289(4):
E617 - E626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Uckaya, P Delagrange, A Chavanieu, G Grassy, M-F Berthault, A Ktorza, E Cerasi, G Leibowitz, and N Kaiser
Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue
J. Endocrinol.,
March 1, 2005;
184(3):
505 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hatakeyama, Y. Sakata, S. Takakura, T. Manda, and S. Mutoh
Acute and chronic effects of FR-149175, a {beta}3-adrenergic receptor agonist, on energy expenditure in Zucker fatty rats
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2004;
287(2):
R336 - R341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Granneman, M. Burnazi, Z. Zhu, and L. A. Schwamb
White adipose tissue contributes to UCP1-independent thermogenesis
Am J Physiol Endocrinol Metab,
December 1, 2003;
285(6):
E1230 - E1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|